Insider · CIK 0001772054
Stephanie Lovell
Files at TMDX (TransMedics Group, Inc.). First filing Mar 6, 2026, latest Mar 6, 2026.
In brief
Stephanie Lovell files SEC Form 4 as director at TMDX (TransMedics Group, Inc.). Since Mar 6, 2026, Stephanie Lovell has reported 0 open-market buys worth $0 and 1 open-market sell worth $178k, the latest filed on Mar 6, 2026.
A track record needs three past buys with six months of prices behind them; Stephanie Lovell has 0, so none is measured yet.
The newest scored trade: sold $178k of TMDX on Mar 4, 2026, filed Mar 6, 2026, scored 52 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $178k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TMDX: TransMedics Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | TransMedics Group, Inc. | $178k 1,193 shares | -29% | +129% from low-2% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 4, 2026 | TMDX TRANSMEDICS GROUP, INC. | 1,193 0.00% of outstanding | $178k | Mar 4, 2026 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +2,922 | $0.00 | $0 | 5,788 | May 22, 2026 |
| Mar 4, 2026 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock | -1,193 | $149.62 | $178k | 2,866 | Mar 6, 2026 |
| May 22, 2025 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +2,134 | $0.00 | $0 | 4,059 | May 23, 2025 |
Questions about Stephanie Lovell
Answered from the filings on this page, as of the latest one.
Is Stephanie Lovell buying or selling?
In the last 12 months Stephanie Lovell reported 0 open-market buys worth $0 and 1 open-market sell worth $178k on SEC Form 4; the latest was sold $178k of TMDX on Mar 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Stephanie Lovell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephanie Lovell has 0.
Where does Stephanie Lovell file Form 4?
Stephanie Lovell has filed Form 4 at TMDX (TransMedics Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.